SARS-COV-2 and Ocular Surface: From Physiology to Pathology, a Route to Understand Transmission and Disease
Open Access
- 12 February 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 12, 612319
- https://doi.org/10.3389/fphys.2021.612319
Abstract
Coronaviruses gained public attention during the severe acute respiratory syndrome (SARS) outbreak in East Asia in 2003 and spread of Middle Eastern respiratory syndrome (MERS) in 2012. Direct human-to-human contact and droplet are the main methods of transmission. Viral stability in aerosols on different surfaces supports evidence on indirect viral acquisition from fomites through the mucous membranes of the mouth, nose, and eyes. Given the pandemic circumstances, the level of evidence in COVID-19 and ophthalmology regarding eye infection, conjunctival transmission, and viral shedding through tears is insufficient. Presently, conjunctival transmission of coronaviruses has not been confirmed and remains controversial. Considering the physiology of the lacrimal system and ocular surface, the eyes are considered an immunoprotective site, with several antiviral molecules and anti-inflammatory proteins. Nevertheless, they represent an interface with the exterior world and face daily putative aggressors. Understanding the host's ocular surface immunological and protective environment is crucial to clarify the potential of the conjunctiva as an entry route for SARS-CoV-2 and as part of this viral infection. We will discuss hypothetical ocular surface transmission mechanisms and related counterarguments addressed to both angiotensin-converting enzyme 2 receptors found on the conjunctival and corneal epithelia and lactoferrin, lysozyme, lipocalin and secretory IgA levels in the tear film. Hopefully, we will promote better understanding of this organ in COVID-19 infection and the potential transmission route that can be helpful in setting recommendations on best practices and protective guidelines to mitigate the disease spread.Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo
This publication has 58 references indexed in Scilit:
- A Case for the Ancient Origin of CoronavirusesJournal of Virology, 2013
- Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate ProteoglycansPLOS ONE, 2011
- Human Tear Lipocalin Exhibits Antimicrobial Activity by Scavenging Microbial SiderophoresAntimicrobial Agents and Chemotherapy, 2004
- The severe acute respiratory syndrome coronavirus in tearsBritish Journal of Ophthalmology, 2004
- Antimicrobial Properties of Lysozyme in Relation to Foodborne Vegetative BacteriaCritical Reviews in Microbiology, 2003
- Antifungal Effects of Lysozyme and Lactoferrin against Genetically Similar, Sequential Candida albicans Isolates from a Human Immunodeficiency Virus-Infected Southern Chinese CohortJournal of Clinical Microbiology, 2001
- Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system.British Journal of Ophthalmology, 1996
- Family and Generic Names for Viruses Approved by the International Committee on Taxonomy of Viruses, June 1974Intervirology, 1974
- An iron-binding protein common to many external secretionsClinica Chimica Acta; International Journal of Clinical Chemistry, 1966
- Antiviral Activity of LysozymeNature, 1959